[The characteristics of cardiosclerosis in dilated cardiomyopathy]

Biulleten' Vsesoiuznogo Kardiologicheskogo Nauchnogo Tsentra AMN SSSR
|January 1, 1989
PubMed

Insights

Cardiosclerosis (CS) severity in dilated cardiomyopathy (DCMP) correlates with disease duration and infective onset. However, CS severity showed no direct relationship with patient age or heart weight in this study.

Area of Science:

  • Cardiology
  • Pathology
  • Medical Research

Background:

  • Dilated cardiomyopathy (DCMP) is a significant cardiac condition characterized by heart muscle enlargement and weakening.
  • Cardiosclerosis (CS) refers to the hardening or scarring of heart tissue, a common finding in various heart diseases.
  • Understanding the factors influencing CS severity in DCMP is crucial for patient prognosis and management.

Purpose of the Study:

  • To investigate the relationship between cardiosclerosis (CS) severity and clinicopathological factors in patients with dilated cardiomyopathy (DCMP).
  • To examine correlations with patient age, etiological factors, disease duration, and heart weight.
  • To determine the distribution of CS in different cardiac segments in DCMP.

Main Methods:

  • Retrospective analysis of 52 deceased patients diagnosed with dilated cardiomyopathy (DCMP).
  • Assessment of cardiosclerosis (CS) severity across all heart segments.
  • Correlation analysis of CS severity with patient age, etiological factors, disease duration, and heart weight.

Main Results:

  • Diffuse and focal cardiosclerosis (CS) were prevalent in all heart segments of dilated cardiomyopathy (DCMP) patients, even in macroscopically normal areas.
  • CS was most frequent in the left ventricle (92.3%), followed by the ventricular septum (86.5%), and right ventricle (68.2%).
  • CS severity showed a direct relationship with disease duration and was more prevalent in DCMP cases with an infective onset; no correlation with heart weight or age was found.

Conclusions:

  • Cardiosclerosis (CS) is a widespread finding in dilated cardiomyopathy (DCMP), affecting all cardiac regions.
  • Disease duration and infective etiology are significant factors associated with increased CS severity in DCMP.
  • Further research may elucidate the specific mechanisms linking these factors to CS progression in DCMP.

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...